Thursday, 14 November 2019
The National Business Awards Honour Dr Nik
Pharmaceuticals boss and business leader Dr Nik Kotecha OBE has been named the Entrepreneur of the Year at this year’s Lloyds Bank National Business Awards.
The flagship national awards, held at Grosvenor House, in London, each year honour the UK’s most creative and innovative businesses and business leaders, who set new standards of excellence within their industries.
Dr Kotecha was nominated alongside some of the country’s most inspiring and visionary entrepreneurs for his work in growing Chamber strategic partner, Morningside Pharmaceuticals from a garage start-up in the 1990s to one of the Midlands’ leading life sciences businesses, today.
Morningside Pharmaceuticals, based in Loughborough, manufactures and supplies quality medicines to the UK and internationally. Since inception, the company has exported to more than 100 countries globally, as well as supplies NHS hospitals and pharmacies twice daily in the UK.
Dr Kotecha said: “I am truly honoured and humbled to receive this award, which I would like to dedicate to the hard work, dedication and commitment of our employees.
“Morningside was founded through an entrepreneur’s dream of making quality healthcare an affordable and accessible reality throughout the world, and has grown to become one of the Top 100 companies in our county of Leicestershire, today.
“Our focus has been on innovating and developing niche generic drugs, which in turn has enabled Morningside to grow to a size, so we are in a position to support a wide range of good causes connected to sport, education, health and the community.
“Our commitment is to work with communities to bring them together and to improve the quality of life of the people living there. I hope this national award helps shine a light on how successful businesses - through corporate social responsibility - can make a real difference to the communities they operate in.”
In the true spirit of an entrepreneur, Dr Kotecha was also honoured for establishing his own Charitable Foundation, which is focussed on saving lives, helping the socially disadvantaged and improving the quality of life for those in need in the UK and around the world.
Dr Kotecha added: “The Randal Charitable Foundation’s focus is to support issues connected to health, disability, mental health, poverty and social disadvantage, and we’re delighted to have already been able to donate significant grant funding to a number of local, national and international good causes.”
As well as his business and philanthropic work; Dr Kotecha also gives his time to the local community through involvement with Board and Advisory positions for business organisations, government departments, industry associations and charities. This includes being a CBI Regional Councillor and a Department for International Trade (DIT) Export Champion.
The judges were impressed with Dr Kotecha’s history of innovating to grow his businesses. They also commended his clear philosophy of learning every part of his companies in detail, while building a team around him, and then moving onto his next challenge.
Richard Alvin, Interim Awards Director, said: “The leaders we meet are truly inspirational, and Dr Nik Kotecha’s work with Morningside Pharmaceuticals is a stellar example of the innovation and leadership it takes to grow an organisation from the ground up. We’re delighted to be able to celebrate this incredible story of UK and international success.”
Speaking about the level of competition this year, Mr Alvin, added: “This year’s awards have seen fierce competition in every single category, building pride in every inch of our country.
“I would like to extend the warmest of congratulations to all of this year’s winners. Our entrants face the most rigorous of judging processes, so it’s no mean feat getting on the shortlist, never mind actually winning one.
“However, our winners this year have all proved themselves to be world-class British businesses and we hope that these awards continue to succeed in offering them the credibility and encouragement to continue in their ambitious success.”
For more information about Morningside Pharmaceuticals visit here.Back